Completed
Isoprinosine's Immunopharmacological Dose Evaluation in Immunodepressed Males
What is being tested
Inosine pranobex
Drug
Who is being recruted
Blood-Borne Infections+15
+ Urogenital Diseases
+ Genital Diseases
Over 18 Years
+5 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Summary
Principal SponsorNewport Pharmaceuticals International
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
This study aims to find the best dose of Isoprinosine for boosting the immune system in men with weakened immunity. It focuses on a specific group of male volunteers who have certain immune system issues. The goal is to understand how Isoprinosine can help improve their immune response and overall health. This research is important as it could lead to better treatments for people with similar immune problems.
Principal SponsorNewport Pharmaceuticals International
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Male
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Blood-Borne InfectionsUrogenital DiseasesGenital DiseasesCommunicable DiseasesImmunologic Deficiency SyndromesImmune System DiseasesInfectionsRetroviridae InfectionsRNA Virus InfectionsSexually Transmitted DiseasesSlow Virus DiseasesVirus DiseasesSexually Transmitted Diseases, ViralLentivirus InfectionsAcquired Immunodeficiency SyndromeAIDS-Related ComplexNeoplasmsHIV Infections
Criteria
5 exclusion criteria prevent from participating
Critically ill patients
Patients receiving steroids, cytotoxic immunosuppressive agents, and/or radiotherapy
Patients who have received any other immunotherapy
Patients with a history of gout, urolithiasis, nephrolithiasis, renal dysfunction, and severe gastric ulcer
Show More Criteria
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Newport Pharmaceuticals International Inc
Laguna Hills, United StatesOpen Newport Pharmaceuticals International Inc in Google MapsCompletedOne Study Center